Quantamental Technologies’s Novo Nordisk NVO Stock Holding History

Quantamental Technologies’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-13,664	Closed	-$1.11M	–	493
2023 Q2	$1.11M	Buy	+13,664	New	+$1.12M	0.46%	52
2022 Q4	–	Sell	-6,038	Closed	-$301K	–	604
2022 Q3	$301K	Sell	6,038 -13,408	-69%	-$718K	0.12%	308
2022 Q2	$1.08M	Buy	+19,446	New	+$1.08M	0.5%	42
2022 Q1	–	Sell	-18,400	Closed	-$1.03M	–	504
2021 Q4	$1.03M	Buy	+18,400	New	+$997K	0.52%	42
2021 Q2	–	Sell	-8,812	Closed	-$297K	–	266
2021 Q1	$297K	Buy	+8,812	New	+$314K	0.95%	52
2020 Q3	–	Sell	-20,656	Closed	-$676K	–	338
2020 Q2	$676K	Buy	+20,656	New	+$659K	0.45%	73
2019 Q2	–	Sell	-1,552	Closed	-$41K	–	1701
2019 Q1	$41K	Buy	+1,552	New	+$38.1K	0.02%	923

Other funds holding NVO

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Quantamental Technologies's NVO Position: Q3 2023 in Review

Quantamental Technologies sold out of Novo Nordisk (NVO) in Q3 2023, closing a stake of 13,664 shares — an estimated $1.11M sold.

Quantamental Technologies first reported a position in NVO in Q1 2019 and held it in 7 quarters. The position peaked at $1.11M in Q2 2023. 1,308 funds tracked by Wall St. Rank hold NVO as of Q3 2023.

Quantamental Technologies reported no remaining Novo Nordisk position as of Q3 2023 after selling out during the quarter.
Quantamental Technologies sold 13,664 Novo Nordisk shares in Q3 2023, an estimated $1.11M.
Quantamental Technologies first reported a position in Novo Nordisk in Q1 2019 and held it in 7 quarters.
Quantamental Technologies's Novo Nordisk position peaked at $1.11M in Q2 2023.
1,308 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2023.

Based on Quantamental Technologies's 13F filing for Q3 2023, filed 14 Nov 2023.